|
Real-time Estimate
Cboe BZX
21:43:31 05/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.755 USD | -6.03% |
|
+7.16% | -54.13% |
| Market Cap | 182M 163M 149M 135M 255M 17.24B 262M 1.79B 714M 9.13B 685M 670M 28.81B | P/E 2026 * |
-1.26x | P/E 2027 * | -1.4x |
|---|---|---|---|---|---|
| Enterprise Value | 152M 136M 124M 113M 213M 14.39B 219M 1.49B 596M 7.62B 572M 559M 24.06B | EV / Sales 2026 * |
19.2x | EV / Sales 2027 * | -4.73x |
| Free-Float |
85.81% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TRDA | Delayed | |
CBOE
| TRDA | Real-time |
Last Transcript: Entrada Therapeutics, Inc.
| 21/12/22 | Nipte winst op Wall Street | |
| 20/12/22 | Wall Street licht hoger | |
| 20/12/22 | Wall Street richting rode opening |
| 1 day | -6.62% | ||
| 1 week | +7.16% | ||
| Current month | +3.97% | ||
| 1 month | -13.96% | ||
| 3 months | -33.22% | ||
| 6 months | -70.06% | ||
| Current year | -54.13% |
| 1 week | 4.26 |  | 5.13 |
| 1 month | 4.11 | | 5.75 |
| Current year | 4.11 | | 16.45 |
| 1 year | 4.11 | | 16.45 |
| 3 years | 4.11 | | 21.79 |
| 5 years | 4.11 | | 36.85 |
| 10 years | 4.11 | | 36.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
CEO | Chief Executive Officer | 50 | 01/08/2017 |
Kory Wentworth
DFI | Director of Finance/CFO | 47 | 01/11/2020 |
Nathan Dowden
PSD | President | 56 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
BRD | Director/Board Member | 50 | 01/08/2017 |
Kush Parmar
CHM | Chairman | 45 | 01/12/2020 |
Peter Kim
BRD | Director/Board Member | 67 | 01/12/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 09/09/26 | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 09/09/26 | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 03/09/26 | MPM BioImpact LLC
| Sell | Company | -32,263 | 0.0829% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.03% | +7.16% | -32.06% | -69.85% | 182M | |
| +3.80% | +8.47% | +64.65% | +77.70% | 66.87B | |
| +1.63% | +4.93% | +24.89% | +102.90% | 56.55B | |
| +0.07% | +1.39% | +12.75% | +76.61% | 57.2B | |
| -0.29% | -4.28% | +25.30% | +32.71% | 43.47B | |
| -6.74% | -2.90% | +211.34% | +757.71% | 42.8B | |
| +3.20% | +5.27% | +21.70% | +99.42% | 42.95B | |
| +1.59% | -4.04% | +97.66% | +81.57% | 32.11B | |
| +7.50% | +13.28% | +28.05% | +64.46% | 34.01B | |
| -3.25% | -4.25% | -42.82% | +348.20% | 24.13B | |
| Average | +0.14% | +4.04% | +41.15% | +157.14% | 40.03B | |
| Weighted average by Cap. | +1.09% | +3.91% | +51.44% | +166.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.95M 7.08M 6.48M 5.9M 11.12M 751M 11.42M 77.83M 31.12M 398M 29.84M 29.19M 1.26B | 20.42M 18.2M 16.65M 15.16M 28.58M 1.93B 29.35M 200M 79.97M 1.02B 76.67M 75.02M 3.23B |
| Net income | -174M -155M -142M -129M -244M -16.48B -251M -1.71B -683M -8.73B -654M -640M -27.54B | -184M -164M -150M -137M -258M -17.43B -265M -1.81B -722M -9.23B -692M -677M -29.13B |
| Net Debt | -30.12M -26.84M -24.55M -22.36M -42.15M -2.85B -43.28M -295M -118M -1.51B -113M -111M -4.76B | -279M -249M -227M -207M -390M -26.37B -401M -2.73B -1.09B -13.97B -1.05B -1.03B -44.07B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/11/26 | $4.702 | -7.08% | 67,261 |
| 04/11/26 | $5.060 | +7.20% | 497,634 |
| 03/11/26 | $4.720 | -7.63% | 563,149 |
| 02/11/26 | $5.110 | +12.68% | 652,179 |
| 30/10/26 | $4.535 | +3.07% | 317,344 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TRDA Stock
Select your edition
All financial news and data tailored to specific country editions
